Article Information
- Received June 13, 2018
- Revision received August 15, 2018
- Accepted August 25, 2018
- Published online September 13, 2018.
Author Information
- Aran Groves1,*,
- Yasuyuki Kihara1,*,
- Deepa Jonnalagadda1,*,
- Richard Rivera1,
- Grace Kennedy1,
- Mark Mayford2 and
- Jerold Chun1
- 1Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037
- 2Department of Psychiatry, University of California San Diego, La Jolla, CA 92037
- Correspondence should be addressed to Jerold Chun. 10901 N. Torrey Pines Road, La Jolla, CA 92037. E-mail: jchun{at}sbpdiscovery.org.
Author contributions
Author contributions: J.C. conceived of initial concepts. A.G., Y.K., D.J., R.R., and G.K., performed research; A.G., Y.K., and D.J., analyzed research; M.M. contributed unique mice; and Y.K., D.J., A.G., and J.C. wrote the manuscript.
↵* A.G., Y.K., and D.J. contributed equally to this work.
Disclosures
J.C. has received honoraria, consulting fees, and grant support from Novartis. All other authors declare no competing financial interests.
This work was supported by a grant from NIH DA019674 and NS084398 (J.C.) and Novartis (J.C.), NIH NS103940 (Y.K.) a fellowship from the Uehara Memorial Foundation, the Kanae Foundation for the Promotion of Medical Science, Mochida Memorial Foundation for Medical and Pharmaceutical Research, and the Human Frontier Science Program (Y.K.). A.G was supported by Medical Scientist Training Program and Pharmacology Training Grant at University of California San Diego (T32GM007752).
Funding
Novartis
HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS)
R01NS103940
Other Version
- You are viewing the most recent version of this article.
- previous version (September 13, 2018).
Online Impact